Publications

Detailed Information

Gender Difference in the Prodromal Symptoms of First-episode Schizophrenia

DC Field Value Language
dc.contributor.authorChoi, Jung-Seok-
dc.contributor.authorChon, Myong-Wuk-
dc.contributor.authorKang, Do-Hyung-
dc.contributor.authorJung, Myung Hun-
dc.contributor.authorKwon, Jun Soo-
dc.date.accessioned2012-07-05T01:17:52Z-
dc.date.available2012-07-05T01:17:52Z-
dc.date.issued2009-12-
dc.identifier.citationJOURNAL OF KOREAN MEDICAL SCIENCE; Vol.24 6; 1083-1088ko_KR
dc.identifier.issn1011-8934-
dc.identifier.urihttps://hdl.handle.net/10371/78536-
dc.description.abstractTo investigate the gender difference of early symptoms appearing before the onset of the psychotic symptoms in patients with first-episode schizophrenia, we reviewed the medical records of 63 patients (38 males, 25 females), who were hospitalized for first-episode schizophrenia. The frequency and duration of prodromal and psychotic symptoms, Clinical Global Impression scale scores, Global Assessment of Functioning (GAF) scale scores at admission, and other clinical characteristics were recorded for all patients. Overall, the most common prodromal symptoms were attenuated positive symptoms (89%), followed by mood symptoms (86%). Negative symptoms were the most common in male patients (97.4%), whereas attenuated positive symptoms were the most common in female patients (84%). Male patients demonstrated more frequent negative, cognitive, and obsessive-compulsive symptoms than female patients did and also showed a tendency of having negative symptoms for the longer period. Correlational analysis showed a significant negative correlation between the duration of negative symptoms and GAF scores at admission in male patients. Our findings suggest that different patterns of prodromal symptoms between male and female begin before the onset of the psychosis. Further prospective studies should be needed.ko_KR
dc.description.sponsorshipThis paper was supported by a grant (M103KV010012-
08K2201-01210) from Brain Research Center of the
21st Century Frontier Research Program funded by
the Ministry of Science and Technology, Republic of
Korea.
ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN ACAD MEDICAL SCIENCESko_KR
dc.subjectSchizophreniako_KR
dc.subjectProdrome of Schizophreniako_KR
dc.subjectFirst-episode Schizophreniako_KR
dc.subjectSex Factorsko_KR
dc.titleGender Difference in the Prodromal Symptoms of First-episode Schizophreniako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최정석-
dc.contributor.AlternativeAuthor천명욱-
dc.contributor.AlternativeAuthor강도형-
dc.contributor.AlternativeAuthor정명훈-
dc.contributor.AlternativeAuthor권준수-
dc.identifier.doi10.3346/jkms.2009.24.6.1083-
dc.citation.journaltitleJOURNAL OF KOREAN MEDICAL SCIENCE-
dc.description.citedreferenceJeppesen P, 2008, PSYCHOL MED, V38, P1157, DOI 10.1017/S0033291708003449-
dc.description.citedreferenceCannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28-
dc.description.citedreferenceWILLHITE RK, 2008, SCHIZOPHR RES, V104, P237-
dc.description.citedreferenceLAPPIN JM, 2007, BR J PSYCHIAT S, V51, pS123-
dc.description.citedreferenceGoldstein JM, 2006, HORM BEHAV, V50, P612, DOI 10.1016/j.yhbeh.2006.06.029-
dc.description.citedreferenceRosen JL, 2006, SCHIZOPHR RES, V85, P124, DOI 10.1016/j.schres.2006.03.034-
dc.description.citedreferenceAmminger GP, 2006, SCHIZOPHR RES, V84, P67, DOI 10.1016/j.schres.2006.02.018-
dc.description.citedreferenceBarbui C, 2005, J CLIN PSYCHOPHARM, V25, P521, DOI 10.1097/01.jcp.0000185423.15891.02-
dc.description.citedreferencePerkins DO, 2005, AM J PSYCHIAT, V162, P1785-
dc.description.citedreferenceSvirskis T, 2005, SCHIZOPHR RES, V75, P439, DOI 10.1016/j.schres.2004.11.002-
dc.description.citedreferenceNorman RMG, 2005, J NERV MENT DIS, V193, P17, DOI 10.1097/01.nmd.0000149214.17924.d9-
dc.description.citedreferenceYung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0-
dc.description.citedreferenceLieberman JA, 2003, AM J PSYCHIAT, V160, P1396-
dc.description.citedreferenceMcGlashan TH, 2003, SCHIZOPHR RES, V61, P7, DOI 10.1016/S0920-9964(02)00439-5-
dc.description.citedreferenceKinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P55, DOI 10.1016/S0306-4530(02)00127-0-
dc.description.citedreferenceMcGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921-
dc.description.citedreferenceGourzis P, 2002, SCHIZOPHRENIA BULL, V28, P415-
dc.description.citedreferenceNorman RMG, 2001, PSYCHOL MED, V31, P381-
dc.description.citedreferenceBottlender R, 2000, SCHIZOPHR RES, V44, P145-
dc.description.citedreferenceCohen RZ, 2000, CAN J PSYCHIAT, V45, P544-
dc.description.citedreferenceLEUNG A, 2000, ACTA PSYCHIAT SCAN S, V401, P3-
dc.description.citedreferenceGOLDSTEIN JM, 2000, WOMEN SCHIZOPHRENIA, P111-
dc.description.citedreferenceHafner H, 1999, ACTA PSYCHIAT SCAND, V100, P105-
dc.description.citedreferencePohjalainen T, 1998, MOL PSYCHIATR, V3, P256-
dc.description.citedreferenceBehl C, 1997, MOL PHARMACOL, V51, P535-
dc.description.citedreferenceYung AR, 1996, AUST NZ J PSYCHIAT, V30, P587-
dc.description.citedreferenceLarsen TK, 1996, SCHIZOPHRENIA BULL, V22, P241-
dc.description.citedreferenceFOLNEGOVIC Z, 1994, SCHIZOPHR RES, V14, P83-
dc.description.citedreferenceHAFNER H, 1993, BRIT J PSYCHIAT, V162, P80-
dc.description.citedreferenceHAFNER H, 1992, SCHIZOPHR RES, V6, P209-
dc.description.tc2-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share